Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis

Journal of Nuclear Medicine

Volumn 52, Issue 6, 2011, Pages 958-964

  Zhang, Rui ^a   Lu, Wei ^a   Wen, Xiaoxia ^a   Huang, Miao ^a   Zhou, Min ^a   Liang, Dong ^b   Li, Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Annexin A5; Apoptosis; Fluorescence optical imaging; Nuclear imaging; Polymeric micelles

Indexed keywords

CETUXIMAB; CYCLOPHOSPHAMIDE; ETOPOSIDE; HYDRAZINONICOTINAMIDE LIPOCORTIN 5 TC 99M; LIPOCORTIN 5 IN 111; MACROGOL; PACLITAXEL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORE CROSS LINKED POLYMERIC MICELLE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISOTOPE LABELING; LYMPHOMA; MICELLE; MOLECULAR IMAGING; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT;

ANIMALS; ANNEXIN A5; APOPTOSIS; AUTORADIOGRAPHY; CELL LINE; CELL LINE, TUMOR; COLORING AGENTS; CROSS-LINKING REAGENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDIUM RADIOISOTOPES; ISOTOPE LABELING; MICE; MICE, INBRED C57BL; MICELLES; MICROSCOPY, FLUORESCENCE; POLYMERS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79958136891     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.083220     Document Type: Article

References (36)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Tepper CG, Studzinski GP. Resistance of mitochondrial-DNA to degradation characterizes the apoptotic but not the necrotic mode of human leukemia-cell death. J Cell Biochem. 1993;52:352-361. (Pubitemid 23205534)
3. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
4. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189. (Pubitemid 26339772)
5. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol. 1992;149:4029-4035. (Pubitemid 23068888)
6. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic t-lymphocytes. J Exp Med. 1995;182:1597-1601.
7. Thiagarajan P, Tait JF. Binding of annexin-v placental anticoagulant protein i to platelets: evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem. 1990;265:17420-17423.
8. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanoers MHJ. Annexin-v for flow cytometric detection of phosphatidylserine expression on b-cells undergoing apoptosis. Blood. 1994;84:1415-1420. (Pubitemid 24273007)
9. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-binding and phospholipid-binding proteins. Biochim Biophys Acta. 1994;1197:63-93.
10. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin-v binding. J Lab Clin Med. 1994;123:741-748. (Pubitemid 2100636)
11. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880. (Pubitemid 26307087)
12. Zhang G, Gurtu V, Kain SR, Yan GC. Early detection of apoptosis using a fluorescent conjugate of annexin v. Biotechniques. 1997;23:525-531. (Pubitemid 27398205)
13. Schellenberger EA, Weissleder R, Josephson L. Optimal modification of annexin v with fluorescent dyes. ChemBioChem. 2004;5:271-274. (Pubitemid 39257119)
14. Glaser M, Collingridge DR, Aboagye EO, et al. Iodine-124 labelled annexin-v as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isot. 2003;58:55-62. (Pubitemid 35453947)
15. Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a F-18-labelled recombinant annexin-v derivative, for identification and quantification of apoptotic cells with pet. Appl Radiat Isot. 2003;58:201-207. (Pubitemid 36172511)
16. Grierson JR, Yagle KJ, Eary JF, et al. Production of [F-18]fluoroannexin for imaging apoptosis with pet. Bioconjug Chem. 2004;15:373-379. (Pubitemid 38365198)
17. Murakami Y, Takamatsu H, Taki J, et al. F-18-labelled annexin v: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging. 2004;31:469-474. (Pubitemid 38461560)
18. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 1998;95:6349-6354.
19. Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell death) with Tc-99m annexin v. J Nucl Med. 1999;40:184-191. (Pubitemid 29044190)
20. Blankenberg FG, Naumovski L, Tait JF, Post AM, Strauss HW. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using Tc-99m-radiolabeled annexin v. J Nucl Med. 2001;42:309-316. (Pubitemid 32150523)
21. Blankenberg FG, Post AM, Tait JF, Blankenberg TA, Strauss HW. Apoptosis in acute and chronic abscesses [abstract]. J Nucl Med. 2001;42:333P-334P.
22. Post AM, Katsikis PD, Tait JF, Strauss HW, Blankenberg FG. Apoptosis in experimental rheumatoid arthritis [abstract]. J Nucl Med. 2001;42:128P.
23. 99mTc annexin V imaging to evaluate apoptosis in autoimmune myocarditis rats [abstract]. J Nucl Med. 2001;42:45P.
24. 99mTc labeled annexin V in a rat model of suture fusion [abstract]. J Nucl Med. 2002;43:346P.
25. Blankenberg FG. In vivo detection of apoptosis. J Nucl Med. 2008;49:81s-95s.
26. Schellenberger EA, Hogemann D, Josephson L, Weissleder R. Annexin v-clio: a nanoparticle for detecting apoptosis by MRI. Acad Radiol. 2002;9:S310-S311. (Pubitemid 34857703)
27. Van Tilborg GAF, Mulder WJM, Chin PTK, et al. Annexin a5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem. 2006;17:865-868. (Pubitemid 44162601)
28. Blankenberg F. To scan or not to scan, it is a question of timing: technetium-99m-annexin v radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clin Cancer Res. 2002;8:2757-2758. (Pubitemid 35025716)
29. Yang Z, Zheng SY, Harrison WJ, et al. Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules. 2007;8:3422-3428.
30. Al-Ejeh F, Darby JM, Tsopelas C, Smyth D, Manavis J, Brown MP. Apomab (r), a la-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy. PLoS ONE. 2009;4:e4558.
31. 111In-labeled annexin v. J Nucl Med. 2004;45:108-115.
32. Green DR, Beere HM. Apoptosis - gone but not forgotten. Nature. 2000;405:28-29.
33. Wen X, Wu QP, Ke S, et al. Improved radiolabeling of pegylated protein: pegylated annexin v for noninvasive imaging of tumor apoptosis. Cancer Biother Radiopharm. 2003;18:819-827. (Pubitemid 37377317)
34. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR Jr, Banaszak Holl MM. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol. 2007;14:107-115.
35. Schmidt V, Giacomelli C, Lecolley F, Lai-Kee-Him J, Brisson AR, Borsali R. Diblock copolymer micellar nanoparticles decorated with annexin-a5 proteins. J Am Chem Soc. 2006;128:9010-9011. (Pubitemid 44078965)
36. Li C, Wang W, Wu QP, et al. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol. 2006;33:349-358.